Perifosine regulatory update

FDA granted Orphan Drug designation to perifosine to treat neuroblastoma. The small molecule inhibitor of phosphoinositide 3-kinase (PI3K)/protein kinase B (PKB; Akt) is in Phase I testing for recurr...